Frank Comer is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of immunology, particularly in the development of antibodies targeted to fungal cell wall polysaccharides. With a total of four patents to his name, Comer's work is paving the way for advancements in fungal infection treatments.

Latest Patents

Among his latest patents, Comer has developed a compound comprising one or more polysaccharide moieties represented by the formula β(1→4)-[GlcNH—R]-2,5-anhydromannose. This compound can be manufactured by reacting chitosan with an acylating agent to yield a modified chitin/chitosan mixed polymer. The subsequent reaction with a deaminating agent cleaves the mixed polymer at the unacylated chitosan moieties. This innovative compound can be utilized to immunize against fungal infections, and the antibodies specific to this compound can provide protection against such infections.

Career Highlights

Frank Comer is currently associated with Wellstat Vaccines, LLC, where he continues to work on groundbreaking research in immunology. His expertise and innovative approach have led to the development of novel compounds that address critical health challenges.

Collaborations

Comer collaborates with esteemed colleagues, including Francis Michon and Samuel J Wohlstadter, to further enhance the research and development of effective immunization strategies.

Conclusion

Frank Comer's contributions to the field of immunology, particularly in the area of fungal infection treatment, highlight his role as an influential inventor. His innovative patents and collaborations are set to make a significant impact on public health.

This text is generated by artificial intelligence and may not be accurate.